321 related articles for article (PubMed ID: 3078948)
21. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
22. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
Gai XX; Rizzo MG; Valpreda S; Baserga R
Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
24. Regulation of cell cycle duration by c-myc levels.
Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
[TBL] [Abstract][Full Text] [Related]
25. Immortalization by truncated myc or ras genes and synergism between myc and ras genes in cell transformation.
Spandidos DA; Lang JC
Anticancer Res; 1989; 9(4):1149-52. PubMed ID: 2683993
[TBL] [Abstract][Full Text] [Related]
26. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
27. Analysis of growth factor "relaxation" in Chinese hamster lung fibroblasts required for tumoral expression.
Van Obberghen-Schilling E; Pérez-Rodríguez R; Franchi A; Chambard JC; Pouysségur J
J Cell Physiol; 1983 May; 115(2):123-30. PubMed ID: 6188755
[TBL] [Abstract][Full Text] [Related]
28. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
[TBL] [Abstract][Full Text] [Related]
29. Differential tumorigenicity of growth factor-dependent versus -independent CCL39 lung fibroblast lines in nude mice.
Renwick DE; Franchi AJ; Pouysségur JM; Lagarde AE
J Natl Cancer Inst; 1986 Jul; 77(1):105-14. PubMed ID: 3459908
[TBL] [Abstract][Full Text] [Related]
30. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
Pietenpol JA; Howe PH; Cunningham MR; Leof EB
J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
[TBL] [Abstract][Full Text] [Related]
31. Transfection of fibroblasts with activated c-myc confers resistance to antigrowth effects of interferon.
Einat M; Kimchi A
Oncogene; 1988 May; 2(5):485-91. PubMed ID: 2453829
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
33. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha affects LTR-controlled oncogene expression in transformed mouse fibroblasts at the post-transcriptional level.
Seliger B; Stark G; Pfizenmaier K
J Immunol; 1988 Sep; 141(6):2138-44. PubMed ID: 2844896
[TBL] [Abstract][Full Text] [Related]
35. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
37. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes.
Falco JP; Taylor WG; Di Fiore PP; Weissman BE; Aaronson SA
Oncogene; 1988 Jun; 2(6):573-8. PubMed ID: 3290805
[TBL] [Abstract][Full Text] [Related]
38. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
Barr LF; Campbell SE; Tamez P; Casero RA
Clin Cancer Res; 1998 Jun; 4(6):1557-61. PubMed ID: 9626477
[TBL] [Abstract][Full Text] [Related]
39. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
